Article Information
History
- June 5, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Estela Moreno-García, M.D.*,1,
- Verónica Rico, M.D.1,
- Laia Albiach, M.D.1,
- Daiana Agüero, M.D.1,
- Juan Ambrosioni, M.D., Ph.D.1,
- Marta Bodro, M.D., Ph.D.1,
- Celia Cardozo, M.D.1,
- Mariana Chumbita, M.D.1,
- Lorena De la Mora, M.D.1,
- Nicole García-Pouton, M.D.1,
- Carolina Garcia-Vidal, M.D., Ph.D.1,
- Ana González-Cordón, M.D., Ph.D.1,
- Marta Hernández-Meneses, M.D.1,
- Alexy Inciarte, M.D.1,
- Montse Laguno, M.D., Ph.D.1,
- Lorna Leal, M.D., Ph.D.1,
- Laura Linares, M.D.1,
- Irene Macaya, M.D.1,
- Fernanda Meira, M.D.1,
- Josep Mensa, M.D.1,
- Antonio Moreno, M.D.1,
- Laura Morata, M.D., Ph.D.1,
- Pedro Puerta-Alcalde, M.D., Ph.D.1,
- Jhon Rojas, M.D., Ph.D.1,
- Montse Solá1,
- Berta Torres, M.D., Ph.D.1,
- Manuel Torres, M.D.1,
- Adrià Tomé, M.D.1,
- Pedro Castro, M.D., Ph.D.2,
- Sara Fernández, M.D.2,
- Josep Maria Nicolás, M.D., Ph.D.2,
- Alex Almuedo-Riera, M.D.3,
- Jose Muñoz, M.D., Ph.D.3,
- Mariana Jose Fernandez-Pittol, M.D.4,
- Maria Angeles Marcos, M.D., Ph.D.4,
- Dolors Soy, M.D., Ph.D.5,
- José Antonio Martínez, M.D., Ph.D.1,
- Felipe García, M.D., Ph.D.1 and
- Alex Soriano, M.D., Ph.D.†,1
- 1Department of Infectious Diseases, Hospital Clínic-Universitat de Barcelona, IDIBAPS, Barcelona, Spain
- 2Medical Intensive Care Unit, Hospital Clínic-Universitat de Barcelona, IDIBAPS, Barcelona, Spain
- 3Department of International Health, ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
- 4Department of Microbiology, Hospital Clínic-Universitat de Barcelona, IDIBAPS, Barcelona, Spain
- 5Department of Pharmacology, Hospital Clínic-Umversitat de Barcelona, IDIBAPS, Barcelona, Spain
- ↵†Corresponding author:
Alex Soriano, M.D. Ph.D., Department of Infectious Diseases, Hospital Clínic of Barcelona., Carrer de Villarroel 170, 08036, Barcelona, Spain, Phone +34 932 275 400; ext.2887, E-mail: asoriano{at}clinic.cat
↵* both authors contributed equally to this manuscript.
Posted June 05, 2020.
Tocilizumab is associated with reduced risk of ICU admission and mortality in patients with SARS-CoV-2 infection
